PMC:1064873 / 7363-7453
Annnotations
biosemtest
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T6850 | 3-15 | UMLS/C0032950 | denotes | ednisolone ( |
| T6833 | 76-84 | UMLS/C1555900 | denotes | ical par |
| T6819 | 76-84 | UMLS/C1611832 | denotes | ical par |
| T6801 | 76-84 | UMLS/C1608518 | denotes | ical par |
| T6788 | 76-84 | UMLS/C0205210 | denotes | ical par |
| T6730 | 37-74 | UMLS/C0242708 | denotes | ase-modifying antirheumatic drugs. Cl |
| T6691 | 25-31 | UMLS/C0439423 | denotes | ay) an |
| T6688 | 25-31 | UMLS/C0439422 | denotes | ay) an |
pmc-enju-pas
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T6942 | 72-80 | JJ | denotes | Clinical |
| T6941 | 65-70 | NN | denotes | drugs |
| T6940 | 51-64 | JJ | denotes | antirheumatic |
| T6939 | 33-50 | JJ | denotes | disease-modifying |
| T6938 | 29-32 | CC | denotes | and |
| T6937 | 27-28 | -RRB- | denotes | ) |
| T6936 | 21-27 | NN | denotes | mg/day |
| T6935 | 17-20 | CD | denotes | 7.5 |
| T6934 | 15-16 | SYM | denotes | ≤ |
| T6933 | 14-15 | -LRB- | denotes | ( |
| T6932 | 1-13 | NN | denotes | prednisolone |
| R3251 | T6932 | T6933 | arg1Of | prednisolone,( |
| R3252 | T6932 | T6938 | arg1Of | prednisolone,and |
| R3253 | T6935 | T6934 | arg1Of | 7.5,≤ |
| R3254 | T6936 | T6933 | arg2Of | mg/day,( |
| R3255 | T6936 | T6935 | arg1Of | mg/day,7.5 |
| R3256 | T6937 | T6933 | arg3Of | ),( |
| R3258 | T6941 | T6938 | arg2Of | drugs,and |
| R3259 | T6941 | T6939 | arg1Of | drugs,disease-modifying |
| R3260 | T6941 | T6940 | arg1Of | drugs,antirheumatic |
bionlp-st-ge-2016-test-ihmc
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T7310 | 33-70 | Entity | denotes | disease-modifying antirheumatic drugs |
| T7307 | 1-28 | Entity | denotes | prednisolone (≤ 7.5 mg/day) |
bionlp-st-ge-2016-spacy-parsed
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T7152 | 72-80 | JJ | denotes | Clinical |
| T7151 | 70-71 | . | denotes | . |
| T7150 | 65-70 | NNS | denotes | drugs |
| T7149 | 51-64 | JJ | denotes | antirheumatic |
| T7148 | 33-50 | JJ | denotes | disease-modifying |
| T7147 | 29-32 | CC | denotes | and |
| T7146 | 27-28 | -RRB- | denotes | ) |
| T7145 | 21-27 | NN | denotes | mg/day |
| T7144 | 17-20 | CD | denotes | 7.5 |
| T7143 | 15-16 | CD | denotes | ≤ |
| T7142 | 14-15 | -LRB- | denotes | ( |
| T7141 | 1-13 | NN | denotes | prednisolone |
| R3459 | T7142 | T7141 | punct | (,prednisolone |
| R3460 | T7143 | T7141 | appos | ≤,prednisolone |
| R3461 | T7144 | T7145 | nummod | 7.5,mg/day |
| R3462 | T7145 | T7143 | appos | mg/day,≤ |
| R3463 | T7146 | T7145 | punct | ),mg/day |
| R3464 | T7147 | T7145 | cc | and,mg/day |
| R3465 | T7148 | T7150 | amod | disease-modifying,drugs |
| R3466 | T7149 | T7150 | amod | antirheumatic,drugs |
| R3467 | T7150 | T7145 | conj | drugs,mg/day |